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CORRESPONDENCE
Statin Therapy before Cardiac Surgery: 
Neutral or Detrimental Effects?
To the Editor:
We read the interesting large retrospective study by Kom-
atsu et al. on preoperative chronic statin use in patients 
undergoing coronary artery bypass grafting, valve sur-
gery, or combined procedures.1 Chronic statin therapy 
was associated with no significant difference in prolonged 
mechanical ventilation, pneumonia, in-hospital mortality, 
neurologic outcome, and length of intensive care unit or 
hospital stay,1 suggesting neutral effects on postoperative 
clinical outcome.
It would be interesting to know the incidence of acute 
kidney injury after surgery in the study by Komatsu et al.1 It 
is well known that postoperative acute kidney injury is cru-
cial in patients’ postoperative course and is associated with 
higher mortality rate.2 Two large, high-quality, randomized 
placebo-controlled trials were recently published, respec-
tively, in the New England Journal of Medicine and JAMA. 
Zheng et al.3 randomly assigned 1,922 cardiac surgery 
patients to receive perioperative rosuvastatin or placebo, 
started 1 to 8 days before surgery, and the authors found 
that perioperative statins did not prevent postoperative 
atrial fibrillation or perioperative myocardial damage, but 
acute kidney injury was more common in patients receiv-
ing rosuvastatin. Billings et al.4 randomized 617 patients 
to high-dose perioperative atorvastatin or placebo, started 
the day before surgery, and found increased acute kidney 
injury in statin-naive patients with chronic kidney disease. 
A recent systematic review and meta-analysis of random-
ized controlled trials with low risk of bias found that peri-
operative statin therapy was associated with an increased 
incidence of postoperative acute kidney injury as compared 
with placebo, with 314 of 1,318 patients (23.82%) in 
the statin group having acute kidney injury versus 262 of 
1,319 patients (19.86%) in the placebo group (odds ratio 
1.26 [95% CI, 1.05 to 1.52]; P = 0.01).5 Notably, a trend 
toward increased mortality was noted in the statin group: 
9 of 1,318 (0.68%) patients died in the statin group versus 
2 of 1,319 (0.15%) in the placebo group (odds ratio 1.26 
[95% CI, 1.05 to 1.52]; P = 0.06).5 Since the trials included 
in the meta-analysis randomized patients to a short course 
of preoperative statin regimen (between 1 and 7 days), we 
would like to ask Komatsu et al. for further data regard-
ing length of preoperative statin therapy and, if available, a 
stratification according to it (e.g., short-term vs. long-term 
statins administration).
In conclusion, there is growing high-quality evidence3–5 
that suggests not administering statins in the days before car-
diac surgery. Statins in the days before cardiac surgery are not 
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Neurocritical Care Needs Predictive 
Scores That Succeed at Predicting 
Failure as Well as They Predict 
Success
To the Editor:
In the August 2017 issue of ANESTHESIOLOGY, Asehnoune et al. 
report their derivation of a novel bedside scoring system to 
predict extubation success in the intubated brain-injured 
patient.1 Many brain-injured patients are likely exposed to 
excess ventilated days because they do not meet extubation 
criteria originally established in general intensive care unit 
(ICU) populations.2 Careful consideration is required, how-
ever, before routinely utilizing new extubation prognostication 
only unuseful, as also suggested by the observational study of 
Komatsu et al.,1 but are harmful to renal function,2–4 and a 
detrimental effect on survival could not be excluded.4 There 
is compelling need for further large, high-quality, random-
ized placebo-controlled trials to confirm these findings and 
to assess the most appropriate time-point of statin discon-
tinuation before cardiac surgery.
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scores. Although the VISAGE (visual pursuit, swallowing, age, 
Glasgow coma scale for extubation) score performs well at pre-
dicting extubation success based on favorable neurologic indi-
cators, it does not adequately predict which patients will fail 
extubation due to neurologic dysfunction.
Recovery of arousal and airway protective reflexes after 
neurologic injury often is slow, and a subset of patients will 
benefit from early tracheostomy without an extubation 
attempt. The VISAGE score poorly discriminates extuba-
tion success among patients with low scores. Based on this 
model, a patient under 40 yr old without visual pursuit 
or swallowing efforts, and with a Glasgow coma scale less 
than 10, would have an almost 60% chance of extubation 
success. Barring a prediction of rapid neurologic improve-
ment or barriers to safe reintubation, we believe that this 
individual should undergo a trial extubation. We are con-
cerned that adoption of a scoring system with explicit or 
perceived cut-points would lead to such patients remaining 
intubated longer than necessary. A similar problem arises 
from the predictive score introduced in ANESTHESIOLOGY ear-
lier this year by Godet et al.3 Although their regression-
based score has a clear inflection point, fully one third of 
patients below this score were successfully extubated. At 
the suggested cut-point, their score falls short of the degree 
of negative predictive value originally reported for the 
Rapid Shallow Breathing Index (RSBI) in a general ICU 
population.4 The negative predictive value for the VISAGE 
score at a cut-point of 3 performs even worse.
Timely extubation of all ICU patients, including those 
with brain injury, helps prevent ventilator-associated 
complications. Although our colleagues highlight that 
brain-injured patients can be safely extubated, we cau-
tion against rigorously applying these scores due to the 
possibility of excess mechanical ventilation for patients 
who score poorly. Extubation failure and reintubation 
is certainly not without risk and is predictive of worse 
outcomes, though causality has not been established.1,5 
Further development of scoring models with improved 
negative predictive values is needed to identify patients 
who should truly forgo trial extubation. Until these risks 
are further quantified, and such a tool is developed, the 
neurocritical care intensivist will necessarily have to toler-
ate and manage higher reintubation rates than those seen 
in a general ICU population.
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